Aterian, Inc.
Business
Aterian, Inc. is a technology-enabled consumer products company that develops, acquires and sells branded consumer goods primarily through online retail channels. It offers products across home and kitchen appliances, kitchenware, air quality appliances, health and beauty products and essential oils under owned brands such as Squatty Potty, HomeLabs, Mueller Living, PurSteam, Healing Solutions and Photo Paper Direct. The company operates as a single reporting segment deriving revenue from the sale of consumer goods. Its products are distributed mainly via e-commerce marketplaces—primarily Amazon U.S.—as well as other marketplaces and its direct-to-consumer websites, supported by third-party manufacturers and logistics partners.
Summary from filing dated 2025-03-25
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net revenue | 69 | 99 | 143 | 221 | 248 | |
| Cost of goods sold | 30 | 38 | 72 | 116 | 126 | |
| Gross profit | 39 | 61 | 70 | 106 | 122 | |
| Selling and Marketing Expense | 41 | 56 | 82 | 121 | 127 | |
| General and Administrative Expense | 12 | 17 | 20 | 38 | 45 | |
| Impairment loss on intangibles | 4 | 0 | 40 | 3 | — | |
| Total operating expenses | 57 | 73 | 146 | 284 | 156 | |
| Operating loss | −18 | −12 | −76 | −178 | −34 | |
| Interest expense, net | 851,000 | 949,000 | 1 | 3 | 13 | |
| Change in fair value of warrant liabilities | −109,000 | −924,000 | −2 | −470,000 | 26 | |
| Other expense, net | 228,000 | 61,000 | 260,000 | −281,000 | 45,000 | |
| Loss before income taxes | −19 | −12 | −75 | −197 | −235 | |
| Provision (benefit) for income taxes | 41,000 | −47,000 | −867,000 | −376,000 | 532,000 | |
| Net loss | −19 | −12 | −75 | −196 | −236 | |
| Net loss per share, basic and diluted (in dollars per share) | −2.39 | −1.68 | −11.43 | −2.95 | −6.67 | |
| Weighted-average number of shares outstanding, basic and diluted (in shares) | 8 | 7 | 7 | 67 | 35 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash | 5 | 18 | 20 | 44 | 30 | |
| Accounts receivable, net | 2 | 4 | 4 | 5 | 10 | |
| Inventory | 14 | 14 | 20 | 44 | 63 | |
| Prepaid and other current assets | 3 | 3 | 5 | 8 | 21 | |
| Total current assets | 24 | 39 | 50 | 100 | 125 | |
| Property and equipment, net | 729,000 | 685,000 | 775,000 | 853,000 | 1 | |
| Intangibles, net | 4 | 10 | 11 | — | — | |
| Other non-current assets | 389,000 | 381,000 | 138,000 | 813,000 | 3 | |
| Total assets | 30 | 50 | 62 | 156 | 314 | |
| Credit facility | 4 | 7 | 11 | 21 | 33 | |
| Accounts payable | 3 | 3 | 4 | 16 | 22 | |
| Seller notes | 368,000 | 466,000 | 1 | 2 | 8 | |
| Accrued and other current liabilities | 6 | 9 | 9 | 14 | 18 | |
| Total current liabilities | 14 | 19 | 25 | 53 | 84 | |
| Other liabilities | 225,000 | 227,000 | 391,000 | 1 | 360,000 | |
| Total liabilities | 14 | 20 | 26 | 54 | 89 | |
| Commitments and contingencies (Note 12) | — | — | — | — | — | |
| Common stock, $0.0001 par value, 500,000,000 shares authorized and 10,027,046 and 8,750,741 shares outstanding at December 31, 2025 and December 31, 2024, respectively | 9,000 | 9,000 | 9,000 | 8,000 | 5,000 | |
| Additional paid-in capital | 746 | 743 | 737 | 728 | — | |
| Accumulated deficit | −731 | −712 | −700 | −625 | −429 | |
| Accumulated other comprehensive loss | −552,000 | −906,000 | −838,000 | −1 | −468,000 | |
| Total stockholders equity | 15 | 30 | 36 | 102 | 224 | |
| Total liabilities and stockholders' equity | 30 | 50 | 62 | 156 | 314 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 2 | 2 | 4 | 8 | — | |
| Provision for sales returns | −102,000 | 57,000 | −413,000 | 56,000 | 43,000 | |
| Amortization of deferred financing cost and debt discounts | 165,000 | 198,000 | 429,000 | 429,000 | 8 | |
| Stock-based compensation | 2 | 8 | 8 | 15 | 29 | |
| Deferred tax expense | 0 | −5,000 | −1 | 0 | — | |
| Change in inventory provisions | 767,000 | −3 | −3 | 0 | — | |
| Allowance for credit losses | −147,000 | 16,000 | 85,000 | — | — | |
| Accounts receivable | 1 | 427,000 | 205,000 | 6 | −5 | |
| Inventory | −794,000 | 9 | 26 | 19 | −19 | |
| Prepaid and other current assets | 183,000 | 762,000 | 3 | 6 | −8 | |
| Accounts payable, accrued and other liabilities | −964,000 | −2 | −14 | −11 | 14 | |
| Cash (used in) provided by operating activities | −11 | 2 | −13 | −17 | −42 | |
| Purchase of fixed assets | −51,000 | −42,000 | −119,000 | −82,000 | −32,000 | |
| Purchase of minority equity investment | 0 | −200,000 | 0 | — | — | |
| Cash used in investing activities | −51,000 | −242,000 | −244,000 | −677,000 | −45 | |
| Repayments on seller notes | −113,000 | −633,000 | −668,000 | −3 | −10 | |
| Borrowings from MidCap credit facilities | 43 | 61 | 80 | 137 | 49 | |
| Repayments for MidCap credit facilities | −46 | −65 | −90 | −149 | −28 | |
| Insurance obligation payments | −711,000 | −682,000 | −1 | −2 | −3 | |
| Insurance financing proceeds | 1 | 700,000 | 986,000 | 2 | 2 | |
| Cash used in financing activities | −3 | −5 | −11 | 27 | 96 | |
| Net change in cash and restricted cash for the period | −13 | −3 | −24 | 8 | 8 | |
| Foreign currency effect on cash and restricted cash | 323,000 | −61,000 | 306,000 | −528,000 | −477,000 | |
| Cash paid for interest | 882,000 | 1 | 2 | 2 | 6 | |
| Cash paid for taxes | 50,000 | 152,000 | 94,000 | 100,000 | 41,000 | |
| Non-cash consideration paid to contractors | 0 | 620,000 | 321,000 | 1 | — | |
| Non-cash minority equity investment | 0 | 50,000 | 0 | — | — |